Sermorelin
Also called Sermorelin acetate, GRF 1-29, GHRH (1-29), Geref
Educational only, not medical advice. Dosaly reports what has been studied; it isn't a recommendation to use Sermorelin or any amount of it. Talk to a clinician.
Previously approved by the FDA as Geref (sermorelin acetate), now discontinued; no sermorelin product is currently marketed in the US under an FDA approval, and it is not approved by the EMA (as of October 2026).
Research applications
- Testing pituitary growth hormone function (formerly approved diagnostic use)
- Growth hormone deficiency in children (clinical trials)
- Growth hormone, IGF-1 and muscle measures in older men (small studies)
What studies have looked at, not proven uses.
What it is
Sermorelin is a lab-made copy of part of the hormone that tells the body to release growth hormone. It was once FDA-approved for children with growth hormone deficiency, then discontinued.
More detail
Sermorelin is a synthetic copy of the first 29 amino acids of human growth hormone-releasing hormone (GHRH), the shortest fragment that keeps the full activity of the natural hormone. It acts on the pituitary to release growth hormone. It was approved in the United States in the 1990s under the brand Geref, for testing pituitary growth hormone function and for treating children with idiopathic growth hormone deficiency, after clinical trials in children. Small studies in healthy older men looked at growth hormone, IGF-1 and muscle measures. The branded product was later discontinued, and newer controlled research on sermorelin is limited.
Evidence listed here
- 1 human study
- 1 review
Results from cells and animals often don't carry over to people. How to read peptide research
Molecular info
- Class
- Synthetic peptide (GHRH 1-29)
- Length
- 29 amino acids
- Sequence
- H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
- Research areas
- Growth hormone
The first 29 amino acids of human growth hormone-releasing hormone, ending in an amide.
Research
- Human studyMetabolism · 1997Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
Small six-week study in 11 healthy older men.
- ReviewBioDrugs · 1999Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.
Review of its use in diagnosing and treating idiopathic GH deficiency in children.